Characteristics and significance of gut microbiota alterations in patients with acute myocardial infarction and their association with the occurrence of heart failure
5 affiliations
- 1Wuhan University of Science and Technology Faculty of Medicine, Wuhan, Hubei, China
- 2Department of Neurology, Taihe Hospital of Shiyan City, Affiliated to Hubei University of Medicine, Shiyan, Hubei, China
- 3Department of Health Sciences, Dongshin University, Jeollanam-do, Republic of Korea
- 4Characteristic Medical Center of Chinese People’s Armed Police Forces, Tianjin, China
- 5Tianjin Provincial Corps Hospital of Chinese People’s Armed Police Forces, Tianjin, China
Abstract
ObjectiveIn the context of real-world clinical practice, this study aimed to systematically investigate the characteristics of gut microecological alterations in patients with acute myocardial infarction (AMI), elucidate their potential clinical significance, and further analyze the association between gut microbiota imbalance and the short-term occurrence of heart failure (HF) in AMI patients, as well as the related influencing factors.MethodsThis study adopted a single-center retrospective case–control design. A total of 143 AMI patients who received standardized diagnosis and treatment in our hospital between April 2023 and June 2025 were enrolled as the disease group, while 120 healthy volunteers undergoing physical examination during the same period were selected as the control group. Selected cultivable gut microbial groups in both groups were quantitatively assessed using culture-based methods. All AMI patients were followed up for 30 days and were divided into group A (HF occurred, n=44) and group B (HF did not occur, n=99) according to whether HF events occurred during the follow-up period. Differences in gut microbiota composition and cardiac function–related indicators, including N-terminal pro–B-type natriuretic peptide (NT-proBNP) and left ventricular ejection fraction (LVEF), were compared between the two groups. Correlation analysis and multivariable logistic regression models were applied to explore the relationships between the selected gut microbial indicators and cardiac function indicators and to identify factors independently associated with HF occurrence in AMI patients.ResultsCompared with the control group, the disease group showed a significant increase in the number of conditional pathogenic bacteria and aerobic bacteria in the gut, with markedly higher levels of Enterobacter, Enterococcus, Clostridium, fungi, and total aerobic bacteria (P<0.05). In contrast, beneficial bacteria were significantly reduced, as evidenced by decreased levels of Bacteroides, Bifidobacterium, Lactobacillus, and total anaerobic bacteria (P<0.05). Further subgroup analysis revealed that, compared with group B, group A had significantly lower abundances of beneficial bacteria (Bacteroides, Bifidobacterium, Lactobacillus, and total anaerobic bacteria), while the numbers of Enterobacter, Enterococcus, and total aerobic bacteria were markedly increased (P<0.05). Meanwhile, LVEF levels were significantly lower and NT-proBNP levels were significantly higher in group A than in group B (P<0.05). Correlation analysis showed that the numbers of Enterobacter, Enterococcus, and total aerobic bacteria were significantly positively correlated with NT-proBNP levels and negatively correlated with LVEF (P<0.05). Conversely, the numbers of Bacteroides, Bifidobacterium, Lactobacillus, and total anaerobic bacteria were negatively correlated with NT-proBNP and positively correlated with LVEF (P<0.05). Multivariate regression analysis further confirmed that Bacteroides, Bifidobacterium, Lactobacillus, total anaerobic bacteria, LVEF, Enterobacter, Enterococcus, total aerobic bacteria, and NT-proBNP were all independent influencing factors for the occurrence of HF in AMI patients.ConclusionAMI patients exhibit a certain degree of alteration in gut microbiota structure, mainly characterized by a reduction in the abundance of some beneficial bacteria and a relative increase in conditional pathogenic bacteria. These gut microecological changes are associated with cardiac function indicators and the short-term occurrence of HF, suggesting that gut microbiota imbalance may have a potential link with adverse cardiac functional outcomes after AMI. However, given that this study was a single-center retrospective investigation, the findings still require further validation in larger, multicenter, and prospective studies.
Related
- Depolymerized Fucoidan Alleviates High-Fat Diet-Induced Obesity in Association with Alterations in Gut Microbiota and Metabolic Profiles.
- Sample overlap in genome-wide association meta-analysis: practical comparisons across significance thresholds
- Longitudinal analysis of vaccine-associated alterations in the faecal microbiota of layer chickens using a vaccination schedule representative of commercial practice
- The fluorescence patterns of antinuclear antibodies: morphological characteristics, immunological correlations and clinical significance
- Prognostic significance of KIF2C and its association with lactate metabolism in hepatocellular carcinoma
BibTeX
@article{li2026characteristics,
title = {{Characteristics and significance of gut microbiota alterations in patients with acute myocardial infarction and their association with the occurrence of heart failure}},
author = {Boyuan Li and Lizhi Jiang and Haiyu Mao and JunXiang Liu and DongLin Song and Yi Yuan and GuoHong Yang},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
month = nov,
doi = {10.3389/fcimb.2026.1882009},
url = {https://doi.org/10.3389/fcimb.2026.1882009},
note = {CC BY},
}
RIS
TY - JOUR
TI - Characteristics and significance of gut microbiota alterations in patients with acute myocardial infarction and their association with the occurrence of heart failure
AU - Boyuan Li
AU - Lizhi Jiang
AU - Haiyu Mao
AU - JunXiang Liu
AU - DongLin Song
AU - Yi Yuan
AU - GuoHong Yang
PY - 2026
DA - 2026/11/03
JO - Frontiers in Cellular and Infection Microbiology
DO - 10.3389/fcimb.2026.1882009
UR - https://doi.org/10.3389/fcimb.2026.1882009
AB - ObjectiveIn the context of real-world clinical practice, this study aimed to systematically investigate the characteristics of gut microecological alterations in patients with acute myocardial infarction (AMI), elucidate their potential clinical significance, and further analyze the association between gut microbiota imbalance and the short-term occurrence of heart failure (HF) in AMI patients, as well as the related influencing factors.MethodsThis study adopted a single-center retrospective case–control design. A total of 143 AMI patients who received standardized diagnosis and treatment in our hospital between April 2023 and June 2025 were enrolled as the disease group, while 120 healthy volunteers undergoing physical examination during the same period were selected as the control group. Selected cultivable gut microbial groups in both groups were quantitatively assessed using culture-based methods. All AMI patients were followed up for 30 days and were divided into group A (HF occurred, n=44) and group B (HF did not occur, n=99) according to whether HF events occurred during the follow-up period. Differences in gut microbiota composition and cardiac function–related indicators, including N-terminal pro–B-type natriuretic peptide (NT-proBNP) and left ventricular ejection fraction (LVEF), were compared between the two groups. Correlation analysis and multivariable logistic regression models were applied to explore the relationships between the selected gut microbial indicators and cardiac function indicators and to identify factors independently associated with HF occurrence in AMI patients.ResultsCompared with the control group, the disease group showed a significant increase in the number of conditional pathogenic bacteria and aerobic bacteria in the gut, with markedly higher levels of Enterobacter, Enterococcus, Clostridium, fungi, and total aerobic bacteria (P<0.05). In contrast, beneficial bacteria were significantly reduced, as evidenced by decreased levels of Bacteroides, Bifidobacterium, Lactobacillus, and total anaerobic bacteria (P<0.05). Further subgroup analysis revealed that, compared with group B, group A had significantly lower abundances of beneficial bacteria (Bacteroides, Bifidobacterium, Lactobacillus, and total anaerobic bacteria), while the numbers of Enterobacter, Enterococcus, and total aerobic bacteria were markedly increased (P<0.05). Meanwhile, LVEF levels were significantly lower and NT-proBNP levels were significantly higher in group A than in group B (P<0.05). Correlation analysis showed that the numbers of Enterobacter, Enterococcus, and total aerobic bacteria were significantly positively correlated with NT-proBNP levels and negatively correlated with LVEF (P<0.05). Conversely, the numbers of Bacteroides, Bifidobacterium, Lactobacillus, and total anaerobic bacteria were negatively correlated with NT-proBNP and positively correlated with LVEF (P<0.05). Multivariate regression analysis further confirmed that Bacteroides, Bifidobacterium, Lactobacillus, total anaerobic bacteria, LVEF, Enterobacter, Enterococcus, total aerobic bacteria, and NT-proBNP were all independent influencing factors for the occurrence of HF in AMI patients.ConclusionAMI patients exhibit a certain degree of alteration in gut microbiota structure, mainly characterized by a reduction in the abundance of some beneficial bacteria and a relative increase in conditional pathogenic bacteria. These gut microecological changes are associated with cardiac function indicators and the short-term occurrence of HF, suggesting that gut microbiota imbalance may have a potential link with adverse cardiac functional outcomes after AMI. However, given that this study was a single-center retrospective investigation, the findings still require further validation in larger, multicenter, and prospective studies.
SN - 2235-2988
ER -